{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Delta in Management of HDV/HBV Coinfection: Lessons from a Case

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Determine initial assessment for disease progression in patients with Hepatitis D virus infection
  2. Describe the epidemiology of hepatitis D and hepatitis B co-infection
  3. Discuss upcoming new treatment options available for hepatitis D chronic infection

Disclosures

Nancy Reau consults for and advises Gilead and Arbutus; and she received grants from Eiger. The remaining author, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Lippincott CME Institute has identified and mitigated all relevant financial relationships regarding this educational activity.

Price: $30.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: CLD0224C
Published: February 2024
Expires: 1/31/2026
Sources: Clinical Liver Disease
Required Passing Score: 3/4 (75%)
Authors: Manavi Bhagwat and Nancy Reau
Categories: Hepatology
Specialties: Hepatology
Topics: HDV/HBV coinfection